Brain biocompatibility and microglia response towards engineered self-assembling (RADA)4 nanoscaffolds.

Area of Science:

• Biomaterials Science
• Neuroscience
• Tissue Engineering

Background:

• Self-assembling nanoscaffolds offer advantages for tissue engineering, including ease of synthesis and customization.
• Limited data exists on the brain tissue biocompatibility of (RADA)4 nanoscaffolds, particularly concerning glial cell responses.
• Glial cell response is critical for regulating host reactions in neural tissue.

Purpose of the Study:

• To evaluate the in vitro and in vivo biocompatibility of (RADA)4 and (RADA)4-IKVAV nanoscaffolds in brain tissue.
• To assess the effect of these nanoscaffolds on primary microglia and glial cells (astrocytes and microglia) in culture and in vivo.
• To determine if the laminin-derived IKVAV peptide influences glial responses to the nanoscaffolds.

Main Methods:

• Primary microglia were cultured with (RADA)4 and (RADA)4-IKVAV nanoscaffolds.
• In vitro assays included TNF-α, IL-1β, NO, and MTT to assess microglia activation, inflammation, and viability.
• In vivo studies involved intracerebral injection of nanoscaffolds to evaluate glial scarring, axonal injury, and glial cell migration/proliferation.

Main Results:

• Microglia cultured with nanoscaffolds remained ramified and viable, with evidence of phagocytosis without activation.
• Intracerebral injection of nanoscaffolds did not induce microglia migration, proliferation, glial scarring, or axonal injury.
• The IKVAV peptide did not significantly alter microglia activation or astrogliosis.

Conclusions:

• (RADA)4 nanoscaffolds demonstrate excellent biocompatibility with brain tissue, showing no adverse effects on microglia and astrocytes.
• These nanoscaffolds are suitable for localized injection as a tunable platform device.
• The material is expected to be cleared without detrimental effects on resident microglia, positioning it as a promising tool for neural tissue engineering.